{"id":36332,"date":"2015-05-29T10:52:39","date_gmt":"2015-05-29T14:52:39","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=36332"},"modified":"2015-05-29T10:52:39","modified_gmt":"2015-05-29T14:52:39","slug":"call-buyers-active-in-glaxosmithkline-plc-adrnysegsk","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332","title":{"rendered":"Call Buyers Active In GlaxoSmithKline plc (ADR)(NYSE:GSK)"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>GlaxoSmithKline plc (ADR)(NYSE:GSK)<\/strong> is one the U.K. stocks that have hardly fetched any attention of options traders. However, on Friday\u2019s trading session, the <a href=\"http:\/\/www.bloomberg.com\/news\/articles\/2015-05-28\/glaxo-bulls-awaken-with-calls-as-pfizer-merger-chatter-escalates\">call<\/a> buyers are seen making position in company\u2019s stock. The volume in GSK contracts jumped to the record level since 2007, with traders willing to pay higher premiums for bullish options compared to bearish ones. The increased trading activity in company\u2019s stock is largely due to ongoing rumors of GlaxoSmithKline merger with <strong>Pfizer Inc. (NYSE:PFE)<\/strong>.<\/p>\n<p style=\"text-align: justify;\"><strong>The buzz<\/strong><\/p>\n<p style=\"text-align: justify;\">Traders rushed to make positions in GlaxoSmithKline stock as analysts termed the company as a strong potential acquisition target for Pfizer. The deal buzz is making experts believe that company will bend down to growing demand to shake up management. Kari Olsen who is a sales trader at Tavira Monaco Sam said that the buzz is there is if the Chief Executive resigns, the GSK share price can surge as much as 10%. The move will make the people believe that the company will commence restructuring process and sell some assets.<\/p>\n<p style=\"text-align: justify;\"><strong>Options figure<\/strong><\/p>\n<p style=\"text-align: justify;\">As per the report, on an average 800 GlaxoSmithKline options changed hands each day in May. It is 17% more than the average traded GSK options in April. It is the highest volume recorded in the past two years. The stock has declined 11% since last month\u2019s high. The major problem seen with the company is revenue growth.<\/p>\n<p style=\"text-align: justify;\"><strong>The major problem<\/strong><\/p>\n<p style=\"text-align: justify;\">The CEO Andrew Witty is finding it extremely tough to revive revenue growth. U.S sales have been disappointing and investors have blamed the company\u2019s drug pipeline for the dismal performance. Moreover, company\u2019s overall performance was adversely affected by a bribery scandal in China that forced GlaxoSmithKline plc (ADR)(NYSE:GSK) to pay a fine of $455 Million. The Company\u2019s Chairman intends to retain Witty, but investors\u2019 response to rumors indicates the exact opposite. Even the experts believe that a takeover can boost the shares.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GlaxoSmithKline plc (ADR)(NYSE:GSK) is one the U.K. stocks that have hardly fetched any attention of options traders. However, on Friday\u2019s trading session, the call buyers [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":5605,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[11555,1735,993,2745],"stock_ticker":[],"class_list":["post-36332","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-glaxosmithkline-plc-adrnysegsk","tag-nysegsk","tag-nysepfe","tag-pfizer-inc-nysepfe","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Call Buyers Active In GlaxoSmithKline plc (ADR)(NYSE:GSK) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Call Buyers Active In GlaxoSmithKline plc (ADR)(NYSE:GSK) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"GlaxoSmithKline plc (ADR)(NYSE:GSK) is one the U.K. stocks that have hardly fetched any attention of options traders. However, on Friday\u2019s trading session, the call buyers [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-05-29T14:52:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/02\/glaxosmithkline-logo-1260790229.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"Call Buyers Active In GlaxoSmithKline plc (ADR)(NYSE:GSK)\",\"datePublished\":\"2015-05-29T14:52:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332\"},\"wordCount\":333,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/02\/glaxosmithkline-logo-1260790229.jpg\",\"keywords\":[\"GlaxoSmithKline plc (ADR)(NYSE:GSK)\",\"NYSE:GSK\",\"NYSE:PFE\",\"Pfizer Inc (NYSE:PFE)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332\",\"name\":\"Call Buyers Active In GlaxoSmithKline plc (ADR)(NYSE:GSK) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/02\/glaxosmithkline-logo-1260790229.jpg\",\"datePublished\":\"2015-05-29T14:52:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/02\/glaxosmithkline-logo-1260790229.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/02\/glaxosmithkline-logo-1260790229.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Call Buyers Active In GlaxoSmithKline plc (ADR)(NYSE:GSK)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Call Buyers Active In GlaxoSmithKline plc (ADR)(NYSE:GSK) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332","og_locale":"en_US","og_type":"article","og_title":"Call Buyers Active In GlaxoSmithKline plc (ADR)(NYSE:GSK) - Wall Street PR","og_description":"GlaxoSmithKline plc (ADR)(NYSE:GSK) is one the U.K. stocks that have hardly fetched any attention of options traders. However, on Friday\u2019s trading session, the call buyers [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-05-29T14:52:39+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/02\/glaxosmithkline-logo-1260790229.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"Call Buyers Active In GlaxoSmithKline plc (ADR)(NYSE:GSK)","datePublished":"2015-05-29T14:52:39+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332"},"wordCount":333,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/02\/glaxosmithkline-logo-1260790229.jpg","keywords":["GlaxoSmithKline plc (ADR)(NYSE:GSK)","NYSE:GSK","NYSE:PFE","Pfizer Inc (NYSE:PFE)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332","url":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332","name":"Call Buyers Active In GlaxoSmithKline plc (ADR)(NYSE:GSK) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/02\/glaxosmithkline-logo-1260790229.jpg","datePublished":"2015-05-29T14:52:39+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/02\/glaxosmithkline-logo-1260790229.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/02\/glaxosmithkline-logo-1260790229.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/call-buyers-active-in-glaxosmithkline-plc-adrnysegsk-36332#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Call Buyers Active In GlaxoSmithKline plc (ADR)(NYSE:GSK)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36332","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=36332"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36332\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/5605"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=36332"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=36332"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=36332"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=36332"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}